CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Amitriptyline(Endep)","CYP2C19CYP2D6",Major – significant result that may require altering this medication
"Codeine (componentof Acetaminophen-Caffeine-Codeine)","CYP2D6OPRM1",Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
"pregabalin, acetaminophen (component of Acetaminophen-Caffeine-Codeine), caffeine (component ofAcetaminophen-Caffeine-Codeine)",,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -SSRIs",Citalopram,CYP2C19,Reduced / inadequate response,CPIC3
"",Escitalopram,CYP2C19,Reduced / inadequate response,CPIC3
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC1
"",Clomipramine,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC1
"",Doxepin,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC1
"",Imipramine,"CYP2D6CYP2C19",Reduced / inadequate response,CPIC1
Antifungals - Azoles,Voriconazole,CYP2C19,Reduced / inadequate response,CPIC4
Calcineurin inhibitors,Tacrolimus,CYP3A5,Reduced / inadequate response,CPIC5
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Adverse effects,-
Antiarrhythmics,Flecainide,CYP2D6,Adverse effects,DPWG6
"",Propafenone,CYP2D6,Adverse effects,DPWG6
"Antidepressants -other",Moclobemide,CYP2C19,Reduced / inadequate response,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,Adverse effects,DPWG6
"Antidepressants -SSRIs",Paroxetine,CYP2D6,Adverse effects,CPIC3
"",Sertraline,CYP2C19,Reduced / inadequate response,CPIC3
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,Adverse effects,CPIC1
"",Nortriptyline,CYP2D6,Adverse effects,CPIC1
Antidiabetics,Gliclazide,"CYP2C9CYP2C19",Reduced / inadequate response,-
Antiemetics,Ondansetron,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC7
Antihistamines,Chlorpheniramine,CYP2D6,Adverse effects,-
"",Dexchlorpheniramine,CYP2D6,Adverse effects,-
Antiplatelet drugs,Clopidogrel,CYP2C19,Adverse effects,CPIC8
Antipsychotics,Aripiprazole,CYP2D6,Adverse effects,-
"",Brexpiprazole,CYP2D6,Adverse effects,-
"",Haloperidol,CYP2D6,Adverse effects,-
"",Pimozide,CYP2D6,Adverse effects,
"",Risperidone,CYP2D6,Adverse effects,DPWG6
"",Zuclopenthixol,CYP2D6,Adverse effects,DPWG6
Antitussives,Dextromethorphan,CYP2D6,Altered response,-
Benzodiazepines,Clobazam,CYP2C19,Reduced / inadequate response,-
"",Diazepam,CYP2C19,Reduced / inadequate response,-
Beta blockers,Metoprolol,CYP2D6,Adverse effects,DPWG6
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,Reduced / inadequate response,CPIC9
Miscellaneous,Atazanavir,CYP3A5,Reduced / inadequate response,-
"",Cyclophosphamide,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Eliglustat,CYP2D6,Adverse effects,TGA10
"",Proguanil,CYP2C19,Altered response,-
Neurological drugs,Tetrabenazine,CYP2D6,Adverse effects,FDA11
Opioid Analgesics,Morphine,OPRM1,"Associated with reducedresponse to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
Esomeprazole,CYP2C19,Reduced / inadequate response,-,
Lansoprazole,CYP2C19,Reduced / inadequate response,-,
Omeprazole,CYP2C19,Reduced / inadequate response,-,
Pantoprazole,CYP2C19,Reduced / inadequate response,-,
Rabeprazole,CYP2C19,Reduced / inadequate response,-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9",Normal acenocoumarol sensitivity,
"",Warfarin,"VKORC1CYP2C9",Normal warfarin sensitivity,FDA12
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
"",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC3
Antidiabetics,Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC13
Antihistamines,Promethazine,CYP2D6,Adverse effects,-
Antipsychotics,Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
"",Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
"",Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
"",Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
Miscellaneous,Naltrexone,OPRM1,"No altered effect predicted bygenotype for naltrexone",
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
"",Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with reducedsensitivity to codeine",CPIC2
"",Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",DPWG6
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",DPWG6
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Atorvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",-
Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-,
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Simvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",CPIC14,
